Details of the Drug-Related molecule(s) Interaction Atlas

US8481733, 118 Drug Info

SCHEMBL1129553; SCHEMBL1129554; CHEMBL2325937; BDBM98306; US8481733, 118

Cross-matching ID

PubChem CID

44538590

TTD Drug ID

DMZQIKL

General Information of Drug (ID: DMZQIKL)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Activated CDC42 kinase 1 (ACK-1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
BDBM50379214	DMPOVZ6	N. A.	N. A.	Patented	[2]
US8481733, 95	DM36R21	N. A.	N. A.	Patented	[1]
US8481733, 106	DMV6FL8	N. A.	N. A.	Patented	[1]
PMID17280833C30	DMXHS4L	Discovery agent	N.A.	Investigative	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Substituted imidazopyr- and imidazotri-azines. US8481733.
2	Kinase modulators for the treatment of cancer. US9416123.
3	Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and prelimin... Bioorg Med Chem Lett. 2007 Apr 15;17(8):2305-9.